{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:26:28Z","timestamp":1790072788216,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejrad.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T16:09:07Z","timestamp":1411920547000},"page":"2203-2223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["State of the art imaging of multiple myeloma: Comparative review of FDG PET\/CT imaging in various clinical settings"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-755X","authenticated-orcid":false,"given":"Charles","family":"Mesguich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Fardanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Tanenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Kostakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9686","key":"10.1016\/j.ejrad.2014.09.012_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","article-title":"Monoclonal gammopathy of undetermined significance: a consensus statement","volume":"150","author":"Bereson","year":"2010","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.ejrad.2014.09.012_bib0015","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejrad.2014.09.012_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood-2011-01-332320","article-title":"Long-term prognostic significance of response in multiple myeloma after stem cell transplantation","volume":"118","author":"Martinez Lopez","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013","volume":"88","author":"Mikhael","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"10.1016\/j.ejrad.2014.09.012_bib0030","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejrad.2014.09.012_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajh.23390","article-title":"Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management","volume":"88","author":"Rajkumar","year":"2013","journal-title":"Am J Hematol"},{"issue":"18","key":"10.1016\/j.ejrad.2014.09.012_bib0040","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2010-10-300970","article-title":"Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2","volume":"117","author":"Munshi","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejrad.2014.09.012_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.ejrad.2014.09.012_bib0050","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejrad.2014.09.012_bib0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejrad.2014.09.012_bib0060","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3324\/haematol.2012.065359","article-title":"Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma","volume":"97","author":"Hillengass","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.ejrad.2014.09.012_bib0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12185-012-1215-6","article-title":"Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?","volume":"96","author":"Caldarella","year":"2012","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.ejrad.2014.09.012_bib0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ejrad.2014.09.012_bib0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","article-title":"Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography","volume":"178","author":"Mahnken","year":"2002","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur Melnyk","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjh.12346","article-title":"Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review","volume":"162","author":"Regelink","year":"2013","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0090","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","article-title":"Magnetic resonance imaging in the staging of solitary plasmacytoma of bone","volume":"11","author":"Moulopoulos","year":"1993","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejrad.2014.09.012_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0033-1343069","article-title":"Current concepts in MRI of focal and diffuse malignancy of bone marrow","volume":"17","author":"Howe","year":"2013","journal-title":"Semin Musculoskelet Radiol"},{"issue":"5","key":"10.1016\/j.ejrad.2014.09.012_bib0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","article-title":"Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results","volume":"33","author":"Nanni","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ejrad.2014.09.012_bib0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1148\/radiology.168.3.3043546","article-title":"Bone marrow imaging","volume":"168","author":"Vogler","year":"1988","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejrad.2005.01.017","article-title":"Role of MRI for the diagnosis and prognosis of multiple myeloma","volume":"55","author":"Baur-Melnyk","year":"2005","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1470-2045(05)70022-X","article-title":"Malignant spinal-cord compression","volume":"6","author":"Prasad","year":"2005","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejrad.2014.09.012_bib0120","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0730-725X(88)90129-4","article-title":"Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae","volume":"6","author":"Li","year":"1988","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jnnp.58.4.403","article-title":"Imaging of the spinal cord","volume":"58","author":"Stevens","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ejrad.2014.09.012_bib0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2011.08658.x","article-title":"Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology","volume":"153","author":"HIllengass","year":"2011","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s002560050257","article-title":"MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration","volume":"26","author":"Baur","year":"1997","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jmri.20349","article-title":"Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers","volume":"22","author":"Nosas Garcia","year":"2005","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/mrm.1910330408","article-title":"Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography","volume":"33","author":"Hoffmann","year":"1995","journal-title":"Magn Reson Med"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jmri.1880070113","article-title":"Modeling tracer kinetics in dynamic Gd-DTPA MR imaging","volume":"7","author":"Tofts","year":"1997","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"10.1016\/j.ejrad.2014.09.012_bib0155","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdi362","article-title":"Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma","volume":"16","author":"Molopoulos","year":"2005","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejrad.2014.09.012_bib0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.24704","article-title":"Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma","volume":"116","author":"Ailawadhi","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejrad.2014.09.012_bib0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications","volume":"25","author":"Walker","year":"2007","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejrad.2014.09.012_bib0170","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V122.21.3146.3146","article-title":"Prognostic significance of parameters of dynamic contrast-enhanced MRI detecting increased bone marrow microcirculation in monoclonal plasma cell disorders","volume":"122","author":"Hillgengass","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejrad.2014.09.012_bib0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00259-011-1993-8","article-title":"18F-FDG PET\/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation","volume":"39","author":"Derlin","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0180","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-body MRI versus PET in assessment of multiple myeloma disease activity","volume":"192","author":"Shortt","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame","year":"2012","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.ejrad.2014.09.012_bib0190","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/RLU.0b013e31825b2071","article-title":"FDG PET or PET\/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: a systematic review and meta-analysis","volume":"37","author":"Lu","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.ejrad.2014.09.012_bib0195","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/cncr.26467","article-title":"(1)(8)F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review","volume":"118","author":"van Lammeren-Venema","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0200","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2967\/jnumed.111.098830","article-title":"Imaging of multiple myeloma and related plasma cell dyscrasias","volume":"53","author":"Walker","year":"2012","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.ejrad.2014.09.012_bib0205","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354839","article-title":"Positive correlation between baseline PET or PET\/CT findings and clinical parameters in multiple myeloma patients","volume":"131","author":"Park","year":"2013","journal-title":"Acta Haematol"},{"issue":"23","key":"10.1016\/j.ejrad.2014.09.012_bib0215","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejrad.2014.09.012_bib0220","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","article-title":"Value of 18F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma","volume":"38","author":"Hazdenar","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2014.09.012_bib0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00330-012-2600-5","article-title":"Comparative diagnostic performance of (1)(8)F-FDG PET\/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation","volume":"23","author":"Derlin","year":"2013","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.ejrad.2014.09.012_bib0230","first-page":"1457","article-title":"Whole-body (18)F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie","year":"2002","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejrad.2014.09.012_bib0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.2010.01575.x","article-title":"Combining FDG-PET\/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma","volume":"86","author":"Elliott","year":"2011","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.ejrad.2014.09.012_bib0240","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.ejrad.2014.09.012_bib0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.ejrad.2014.09.012_bib0250","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.ejrad.2012.06.028","article-title":"Contrast enhanced MRI and (1)(8)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease","volume":"81","author":"Spinnato","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ejrad.2014.09.012_bib0255","doi-asserted-by":"crossref","first-page":"W790","DOI":"10.2214\/AJR.10.5979","article-title":"Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results","volume":"196","author":"Horger","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"1020","key":"10.1016\/j.ejrad.2014.09.012_bib0260","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1259\/bjr\/52759767","article-title":"Assessing response of myeloma bone disease with diffusion-weighted MRI","volume":"85","author":"Messiou","year":"2012","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.ejrad.2014.09.012_bib0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.09090629","article-title":"Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging","volume":"254","author":"Lin","year":"2010","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.ejrad.2014.09.012_bib0270","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.22572","article-title":"The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma","volume":"109","author":"Horger","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejrad.2014.09.012_bib0275","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"issue":"5","key":"10.1016\/j.ejrad.2014.09.012_bib0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/07357907.2011.584589","article-title":"Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET\/CT and MR imaging","volume":"29","author":"Mulligan","year":"2011","journal-title":"Cancer Invest"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00256-009-0668-z","article-title":"SSH-EPI diffusion-weighted MR imaging of the spine with low b values: is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema?","volume":"38","author":"Oztekin","year":"2009","journal-title":"Skeletal Radiol"},{"issue":"7","key":"10.1016\/j.ejrad.2014.09.012_bib0290","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/10428194.2012.740559","article-title":"Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging \u201cearly myeloma\u201d","volume":"54","author":"Hillengass","year":"2013","journal-title":"Leuk Lymphoma"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X14004550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X14004550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T04:00:31Z","timestamp":1717387231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X14004550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0720048X14004550"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2014.09.012","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State of the art imaging of multiple myeloma: Comparative review of FDG PET\/CT imaging in various clinical settings","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}